GAILEY EYE CLINIC, LTD. – Trademark Portfolio
Entity Type: 03
GAILEY EYE CLINIC, LTD. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GAILEY EYE CLINIC. The owner is based in BLOOMINGTON, IL.
1008 NORTH MAIN STREET
BLOOMINGTON, IL 61701
Showing of trademarks Trademarks
Trademark Classifications
GAILEY EYE CLINIC, LTD.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does GAILEY EYE CLINIC, LTD. have?
GAILEY EYE CLINIC, LTD. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 1 cancelled.
What trademark classes does GAILEY EYE CLINIC, LTD. file in?
GAILEY EYE CLINIC, LTD. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are GAILEY EYE CLINIC, LTD.'s most well-known trademarks?
GAILEY EYE CLINIC, LTD.'s registered trademark portfolio includes well-known marks such as GAILEY EYE CLINIC. These are among 1 currently registered trademark in the portfolio.
What is GAILEY EYE CLINIC, LTD.'s trademark registration success rate?
GAILEY EYE CLINIC, LTD. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.